Clinical Trial Update: 131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinostat [Phase 2]

View source ↗

Summary

Phase 2 trial results for 131I-MIBG alone vs. 131I-MIBG with vincristine and irinotecan vs. 131I-MIBG with vorinostat in neuroblastoma have been completed with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Drugs mentioned

• 131I-MIBG (metaiodobenzylguanidine)
• Irinotecan (Irinotecan)
• Vincristine (vincristine)
• Vorinostat (vorinostat)

Snippet

Sponsor: New Approaches to Neuroblastoma Therapy Consortium | Conditions: Neuroblastoma | Phase 2 | Status: COMPLETED | Results posted: 2022-06-08